| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 83.4 | 83.4 | -43.6 | -76.9 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 28,773.2 | 24,157.4 | 20,517.8 | 18,413.1 |
Net Worth | 28,856.6 | 24,240.8 | 20,474.2 | 18,336.2 |
Minority Interest | ||||
Debt | 3,492.9 | 792.9 | 50.8 | 2,205.4 |
Deferred Tax Liability Net | 609.9 | 511.2 | 339.2 | 422.2 |
Total Liabilities | 32,959.4 | 25,544.9 | 20,864.2 | 20,963.8 |
Fixed Assets | 10,429.2 | 8,800.1 | 8,119.7 | 7,350.8 |
Intangible Assets | ||||
Investments | 13,193.5 | 7,320.6 | 7,440 | 4,936.7 |
Deferred Tax Asset Net | 94.5 | 95.1 | 0 | 441.6 |
Networking Capital | 8,265.4 | 8,112.2 | 4,658.7 | 6,204.2 |
Inventories | 4,575.8 | 4,018.9 | 3,043 | 3,347.8 |
Inventory Days | 84.82 | |||
Sundry Debtors | 5,959 | 4,623.9 | 4,288.9 | 4,945.4 |
Debtor Days | 125.3 | |||
Other Current Assets | 3,156.6 | 4,378.9 | 1,837.4 | 1,865 |
Sundry Creditors | -2,515.2 | -2,432.3 | -2,094.6 | -1,927.7 |
Creditor Days | 48.84 | |||
Other Current Liabilities | -2,910.8 | -2,477.2 | -2,416 | -2,026.3 |
Cash | 976.8 | 1,216.9 | 645.8 | 2,030.5 |
Total Assets | 32,959.4 | 25,544.9 | 20,864.2 | 20,963.8 |
As per the terms agreement, Alvotech and Dr Reddy’s will jointly develop and manufacture the biosimilar candidate and share costs and responsibilities.
Issuance of a Form 483 occurs when an investigator(s) has observed any conditions that in their judgment may constitute violations of the FD&C Act and related Acts.
The board has recommended a final dividend of ₹8 per equity share for FY 2024–25
Here are some of the stocks that may see significant price movement today: Adani Power, Dr Reddy's, and Bank of India, etc.
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.
Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
